Project

ProCure: Defining the future of probiotics for upper respiratory tract diseases

Acronym
ProCure
Code
179J08915
Duration
01 January 2016 → 31 December 2019
Funding
Regional and community funding: various
Research disciplines
  • Medical and health sciences
    • Laboratory medicine
    • Palliative care and end-of-life care
    • Regenerative medicine
    • Other basic sciences
    • Laboratory medicine
    • Palliative care and end-of-life care
    • Regenerative medicine
    • Other clinical sciences
    • Other health sciences
    • Nursing
    • Other paramedical sciences
    • Laboratory medicine
    • Palliative care and end-of-life care
    • Regenerative medicine
    • Other translational sciences
    • Other medical and health sciences
Keywords
respiratory tract diseases
 
Project description

This project aims to explore probiotic strategies that can reduce infections of the upper respiratory tract ( '' upper respiratory tract, '' URT) efficiently. For this purpose will be established a platform (1) to select new probiotic strains for this innovative niche (2) to design innovative processes for the formulation, scaling and applying to develop innovative test these probiotic strains (3) based on cellular, more complex polymicrobial systems and microbioanalysen of the URT. Allows the impact of probiotics will, other diet-related components and pharmaceuticals on the microbiota of the URT can be studied.